INSP
Price
$128.86
Change
+$0.22 (+0.17%)
Updated
Jul 25 closing price
Capitalization
6.35B
9 days until earnings call
XYLO
Price
$5.09
Change
-$0.09 (-1.74%)
Updated
Jul 25 closing price
Capitalization
5.21M
Interact to see
Advertisement

INSP vs XYLO

Header iconINSP vs XYLO Comparison
Open Charts INSP vs XYLOBanner chart's image
Inspire Medical Systems
Price$128.86
Change+$0.22 (+0.17%)
Volume$608.53K
Capitalization6.35B
Xylo Technologies
Price$5.09
Change-$0.09 (-1.74%)
Volume$1.19K
Capitalization5.21M
INSP vs XYLO Comparison Chart in %
Loading...
INSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XYLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INSP vs. XYLO commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSP is a StrongBuy and XYLO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (INSP: $128.86 vs. XYLO: $5.09)
Brand notoriety: INSP and XYLO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: INSP: 108% vs. XYLO: 25%
Market capitalization -- INSP: $6.35B vs. XYLO: $5.21M
INSP [@Medical Specialties] is valued at $6.35B. XYLO’s [@Medical Specialties] market capitalization is $5.21M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INSP’s FA Score shows that 0 FA rating(s) are green whileXYLO’s FA Score has 1 green FA rating(s).

  • INSP’s FA Score: 0 green, 5 red.
  • XYLO’s FA Score: 1 green, 4 red.
According to our system of comparison, XYLO is a better buy in the long-term than INSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INSP’s TA Score shows that 4 TA indicator(s) are bullish while XYLO’s TA Score has 5 bullish TA indicator(s).

  • INSP’s TA Score: 4 bullish, 3 bearish.
  • XYLO’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, XYLO is a better buy in the short-term than INSP.

Price Growth

INSP (@Medical Specialties) experienced а +1.60% price change this week, while XYLO (@Medical Specialties) price change was -1.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was +5.16%, and the average quarterly price growth was -1.87%.

Reported Earning Dates

INSP is expected to report earnings on Aug 04, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSP($6.35B) has a higher market cap than XYLO($5.21M). XYLO YTD gains are higher at: 40.608 vs. INSP (-30.489). XYLO has higher annual earnings (EBITDA): -7.88M vs. INSP (-17.06M). INSP has more cash in the bank: 460M vs. XYLO (27.3M). XYLO has less debt than INSP: XYLO (1.62M) vs INSP (24.8M). INSP has higher revenues than XYLO: INSP (625M) vs XYLO (10.1M).
INSPXYLOINSP / XYLO
Capitalization6.35B5.21M121,900%
EBITDA-17.06M-7.88M217%
Gain YTD-30.48940.608-75%
P/E RatioN/A2.68-
Revenue625M10.1M6,188%
Total Cash460M27.3M1,685%
Total Debt24.8M1.62M1,535%
FUNDAMENTALS RATINGS
INSP vs XYLO: Fundamental Ratings
INSP
XYLO
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
1
Undervalued
PROFIT vs RISK RATING
1..100
80100
SMR RATING
1..100
6547
PRICE GROWTH RATING
1..100
8453
P/E GROWTH RATING
1..100
10052
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XYLO's Valuation (1) in the Medical Specialties industry is significantly better than the same rating for INSP (77). This means that XYLO’s stock grew significantly faster than INSP’s over the last 12 months.

INSP's Profit vs Risk Rating (80) in the Medical Specialties industry is in the same range as XYLO (100). This means that INSP’s stock grew similarly to XYLO’s over the last 12 months.

XYLO's SMR Rating (47) in the Medical Specialties industry is in the same range as INSP (65). This means that XYLO’s stock grew similarly to INSP’s over the last 12 months.

XYLO's Price Growth Rating (53) in the Medical Specialties industry is in the same range as INSP (84). This means that XYLO’s stock grew similarly to INSP’s over the last 12 months.

XYLO's P/E Growth Rating (52) in the Medical Specialties industry is somewhat better than the same rating for INSP (100). This means that XYLO’s stock grew somewhat faster than INSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INSPXYLO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
75%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XYLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRS48.440.99
+2.09%
Leonardo DRS
TIXT4.100.03
+0.74%
TELUS International (Cda)
PROP3.840.02
+0.39%
Prairie Operating Co
BNRG2.10N/A
N/A
Brenmiller Energy Ltd
EQBK38.37-0.37
-0.96%
Equity Bancshares

INSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSP has been loosely correlated with TMCI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if INSP jumps, then TMCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSP
1D Price
Change %
INSP100%
+0.17%
TMCI - INSP
54%
Loosely correlated
-1.55%
MASI - INSP
48%
Loosely correlated
+2.01%
VCYT - INSP
41%
Loosely correlated
+7.04%
RMD - INSP
34%
Loosely correlated
+0.61%
CSTL - INSP
33%
Poorly correlated
-2.19%
More

XYLO and

Correlation & Price change

A.I.dvisor tells us that XYLO and CNMD have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XYLO and CNMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XYLO
1D Price
Change %
XYLO100%
-1.64%
CNMD - XYLO
23%
Poorly correlated
+2.80%
SKHHY - XYLO
23%
Poorly correlated
-1.54%
TWST - XYLO
22%
Poorly correlated
+2.59%
XRAY - XYLO
22%
Poorly correlated
-2.61%
INSP - XYLO
22%
Poorly correlated
+0.17%
More